Non-invasive Tools for PSVD Diagnosis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorNanfang Hospital, Southern Medical University

About this trial

Patients treated with platinum-based chemotherapy drugs have the probability of developing PSVD. The diagnosis of PSVD depends on liver biopsy. In addition, the level of portal vein pressure has guiding value in the diagnosis and prognosis of PSVD. Many studies have shown that liver and spleen stiffness have high accuracy in diagnosis and prognosis. The purpose of this study is to evaluate the efficacy of the combination of liver and spleen stiffness in the diagnosis of PSVD and to search for effective biomarkers for the diagnosis of PSVD through a single-center, prospective, observational study.

Eligibility criteria

Qualifiers

Received platinum chemotherapy for organ tumors;

Ages 18-80;

sign the informed consent voluntarily.

Disqualifiers

Liver pathology suggested cirrhosis;

Underwent liver transplantation;

Combined with hepatocellular carcinoma exceeding Milan criteria;

Complicated with severe heart, kidney, or lung failure;

Trial design

Treatments tested in this trial

  • liver and stiffness measurement

Treatment groups

1,000 Participants
are divided into 1 treatment group